newsfilter
← Latest News
GlobeNewswire·

Aravive Announces Poster Presentation on Batiraxcept at 2023 ASCO Annual Meeting

HOUSTON, April 26, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV, "the Company")), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the